Global Human Chorionic Gonadotropin (HCG) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Human Chorionic Gonadotropin (HCG) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
Human Chorionic Gonadotropin (HCG) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Chorionic Gonadotropin (HCG) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Female Infertility Treatment and Oligospermic Treatment are the major drivers for the industry.
The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Chorionic Gonadotropin (HCG) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Segment by Type
Natural Source Extraction
Recombinant DNA Technology
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Chorionic Gonadotropin (HCG) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Chorionic Gonadotropin (HCG), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Chorionic Gonadotropin (HCG) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Chorionic Gonadotropin (HCG) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Chorionic Gonadotropin (HCG) introduction, etc. Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Chorionic Gonadotropin (HCG) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Human Chorionic Gonadotropin (HCG) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Chorionic Gonadotropin (HCG) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Female Infertility Treatment and Oligospermic Treatment are the major drivers for the industry.
The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Chorionic Gonadotropin (HCG) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Segment by Type
Natural Source Extraction
Recombinant DNA Technology
Segment by Application
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Chorionic Gonadotropin (HCG) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Chorionic Gonadotropin (HCG), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Chorionic Gonadotropin (HCG) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Chorionic Gonadotropin (HCG) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Chorionic Gonadotropin (HCG) introduction, etc. Human Chorionic Gonadotropin (HCG) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Chorionic Gonadotropin (HCG) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices